In Flemingsberg, we cure diseases that were previously considered incurable

Earlier this year we hosted the most meaningful ATMP event of the spring, in collaboration with Miltenyi Biotec and the Karolinska ATMP Center, Karolinska University Hospital and Karolinska Institutet. We gathered over 120 participants, all sharing a vision of creating momentum to accelerate access to ATMPs in the Nordics.

”It’s fantastic, it’s a great opportunity to learn more about what’s going on at Karolinska and for the whole ATMP environment. From the Pre GMP to the manufacturing, to then the clinical trials that they offer here, and I think that’s one of the things that are really unique about the whole Flemingsberg ATMP ecosystem” – Jonathan Clarke, Development Manager at SmartCella.

During the event we launched ATMP Flemingsberg, a platform that encapsulates all the expertise within ATMP in Flemingsberg, from research to clinical implementation.

”We have everything in Flemingsberg and you can see that because they come here from Uppsala and other parts of the world to manufacture their products and do their treatments here” – Ewa Ellis, ATMP coordinator at Karolinska University Hospital.

The seminar shed light on Pre-GMP and GMP, as well as how to advance one’s process to the next level and how Vecura can assist in scaling up. Additionally, Stefan Mielke, an expert in the field, discussed equal access and emphasized the importance of collaborative efforts to make therapies more accessible to patients. Di Yu from Elicera Therapeutics also shared their journey, which began at Vecura in Flemingsberg.

“Clinical trials are very important because they bring innovation to our patients. For those of you who don’t know what CAR-T cells are, they are like glasses for T-cells, so that they can see tumor cells.” – Stephan Mielke, Professor and Scientific Director of the Cancer Center.

Watch our film below, summarizing our successful event. Together, we can accelerate access to ATMPs in the Nordics.

Visit atmpflemingsberg.se

*ATMP (Advanced Therapy Medicinal Products) också kallade Avancerade terapiläkemedel är baserade på celler, vävnader eller gener och delas in i tre huvudkategorier: somatiska cellterapier, genterapier och vävnadstekniska produkter.

Flemingsberg is Growing – A Sustainable and Attractive Neighbourhood in the Making

Flemingsberg is currently undergoing a phase of rapid development, where new rental housing and apartments are helping to strengthen the area’s attractiveness as a residential, education and research hub in southern Greater Stockholm. The expansion of housing is an important part of the long-term development of Campus Flemingsberg and the surrounding area.

From Education to Societal Strength: Police Education and the Fight Against Organized Crime

At a time marked by growing insecurity and increasingly complex crime, the need for long-term solutions is becoming more urgent. As the police training programme at Södertörn University in Flemingsberg celebrates its tenth anniversary, attention is turning to the future. Together with SMOB, the university works with education, research and collaboration to prevent crime and build a safer society.

Taking the leap as a solo developer in Sweden’s growing game industry

Jacques Diringer left a secure job at the game giant King to follow his dream of creating his own game from scratch. In a Stockholm where the gaming industry is growing rapidly and new companies are launched every year, he now embarks on a more uncertain but creative journey. The path has been both challenging and inspiring, shaped by a vibrant gaming community, new collaborations, and the courage to trade stability for freedom.

Previous 234 Next